GNNSF - Genscript Biotech GAAP EPS of -$0.0628 revenue of $304.7M September, 01 2022 06:18 AM Genscript Biotech Corp Genscript Biotech press release ( OTCPK:GNNSF ): 1H GAAP EPS of -$0.0628. Revenue of $304.7M (+32.7% Y/Y). For further details see: Genscript Biotech GAAP EPS of -$0.0628, revenue of $304.7M